Bearish, bull speculation
No adcom straight to approval for the novel drug lumateperone on the 27th of September
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.